Technology · 25 views
University of Washington and Seattle biotech win $245M patent judgment against Guardant
A Seattle biotech built on University of Washington research has won a $245 million patent judgment against Guardant Health over DNA sequencing technology, with the court also ordering ongoing royalties through 2033.
AI Summary
A Seattle biotechnology company that originated from University of Washington research secured a $245 million patent judgment against Guardant Health for alleged infringement of DNA sequencing technology. The court also mandated that Guardant pay ongoing royalties to the biotech through 2033.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Technology
Continue reading recent Technology coverage
- OpenAI says it's cutting off internet access for frontier model trainingContinue reading
- Hottest toy for Christmas? Nvidia CEO plays with adorable Microduck robots, 20,000 sellContinue reading
- Xbox’s first chief operating officer is out after just a few monthsContinue reading
- OpenAI now trains its frontier AI models with no internet accessContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow